Research progress and patent intelligence analysis of the drugs for the treatment of myopia
Myopia,as an ophthalmic disease,is common and complicated in etiology.In recent years,its prevalence is on the rise and the patients are getting younger.If myopia is not corrected and treated in time,it is likely to cause visual damage,which not only causes adverse effects on human life and personal image,but also becomes a serious public health problem for society.Therefore,how to prevent and control myopia and reduce the number of nearsighted people occupy an important position in the field of public health work,causing more researchers to pay attention to this problem.Besides surgical correction,some progress has been made in the treatment of myopia with drugs.In this paper,the targets and patent information of the drugs for myopia treatment are analyzed,so as to contribute to the innovation and development of drugs for myopia correction and treatment.
NETL
NSTL
万方数据
维普
